CRP correlates with clinical score in ulcerative colitis but not in Crohn disease's

被引:54
|
作者
Rodgers, Alexander D. [1 ]
Cummins, Adrian G. [1 ]
机构
[1] Queen Elizabeth Hosp, Dept Gastroenterol & Hepatol, Woodville, SA 5011, Australia
关键词
C-reactive protein; Crohn's disease; erythrocyte sedimentation rate; inflammatory bowel disease; ulcerative colitis;
D O I
10.1007/s10620-006-9691-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The aim of this study was to prospectively evaluate the correlation between clinical scoring systems and C-reactive protein (CRP) in inflammatory bowel disease. The modified Harvey-Bradshaw index was used in 40 patients (58 assessments) with Crohn's disease, and the Lichtiger score in 29 patients (36 assessments) with ulcerative colitis. In ulcerative colitis, CRP was elevated in 14%, 42%, 64%, and 83%, respectively, of subjects with quiescent, mild, moderate, and severe disease. There was a linear correlation of log(CRP) with clinical score except for proctitis. In Crohn's disease, CRP was elevated in 54%, 70%, 75%, and 100%, respectively, of subjects with quiescent, mild, moderate, and severe disease. We conclude that the clinical score has a good correlation with CRP in ulcerative colitis except for proctitis, whereas clinical score has a poor correlation with CRP in Crohn's disease, particularly in those with clinically quiescent, fibrostenotic, and ileal disease.
引用
收藏
页码:2063 / 2068
页数:6
相关论文
共 50 条
  • [21] A family with collagenous colitis, ulcerative colitis, and Crohn's disease
    Chutkan, R
    Sternthal, M
    Janowitz, HD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (12): : 3640 - 3641
  • [22] Chronic inflammatory intestinal diseases:Crohn's disease and ulcerative colitis.: Part 2:: Imaging of ulcerative colitis,treatment of Crohn's disease and ulcerative colitis
    Feuerbach, S
    Scholmerich, J
    RADIOLOGE, 2000, 40 (04): : 415 - 428
  • [23] Concordance of clinical characteristics in both ulcerative colitis and Crohn's disease families
    Annese, V
    Napolitano, G
    Lombardi, G
    Piepoli, A
    Latiano, A
    Bovio, P
    Andriulli, A
    GUT, 1997, 41 : A175 - A176
  • [24] Selective biologics for ulcerative colitis and Crohn's disease - clinical utility of vedolizumab
    Petkau, Jill M. V.
    Eksteen, Bertus
    BIOLOGICS-TARGETS & THERAPY, 2016, 10 : 33 - 52
  • [25] POLYGENIC RISK SCORE INDEPENDENTLY INFLUENCES PSC RISK IN ULCERATIVE COLITIS BUT NOT CROHN'S DISEASE
    Wang, Ming-Hsi
    Friton, Jessica J.
    Raffals, Laura H.
    Leighton, Jonathan A.
    Newberry, Rodney D.
    Faubion, William
    GASTROENTEROLOGY, 2022, 162 (07) : S631 - S632
  • [26] Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis
    Blanchard, JF
    Bernstein, CN
    Wajda, A
    Rawsthorne, P
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 154 (04) : 328 - 335
  • [27] Clinical features and pattern of indeterminate colitis: Crohn's disease with ulcerative colitis-like clinical presentation
    Toshiyuki Matsui
    Tsuneyoshi Yao
    Toshihiro Sakurai
    Kenshi Yao
    Fumihito Hirai
    Hiroaki Matake
    Sumio Tsuda
    Yoko Wada
    Akinori Iwashita
    Sino Kamachi
    Journal of Gastroenterology, 2003, 38 : 647 - 655
  • [28] Clinical features and pattern of indeterminate colitis: Crohn's disease with ulcerative colitis-like clinical presentation
    Matsui, T
    Yao, T
    Sakurai, T
    Yao, K
    Hirai, F
    Matake, H
    Tsuda, S
    Wada, Y
    Iwashita, A
    Kamachi, S
    JOURNAL OF GASTROENTEROLOGY, 2003, 38 (07) : 647 - 655
  • [29] Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis
    Sartor, RB
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (07): : 390 - 407
  • [30] Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
    R Balfour Sartor
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 390 - 407